Technical Analysis for AURA - Aura Biosciences, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Upper Bollinger Band Touch | Strength | 0.00% | |
| Crossed Above 50 DMA | Bullish | -2.51% | |
| MACD Bullish Signal Line Cross | Bullish | -2.51% | |
| Pocket Pivot | Bullish Swing Setup | -2.51% | |
| Volume Surge | Other | -2.51% | |
| Up 3 Days in a Row | Strength | -2.51% | |
| 50 DMA Resistance | Bearish | 1.24% | |
| Slingshot Bearish | Bearish Swing Setup | 1.24% | |
| Crossed Above 20 DMA | Bullish | 1.24% | |
| NR7 | Range Contraction | 1.24% |
| Alert | Time |
|---|---|
| Rose Above Previous Day's High | about 7 hours ago |
| Rose Above Upper Bollinger Band | about 7 hours ago |
| Down 3% | about 7 hours ago |
| Up 3% | about 7 hours ago |
| Down 2 % | about 7 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 08/07/2024
Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform to treat tumors of high unmet need in ocular and urologic oncology. Its AU-011, a VDC candidate, is being developed for the first line treatment of primary choroidal melanoma, a rare disease with no drugs approved. The company also develops AU-011 in additional ocular oncology indications, including choroidal metastases. Aura Biosciences, Inc. was incorporated in 2009 and is headquartered in Cambridge, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Tumor Rare Diseases Melanoma Neoplasms Uveal Melanoma
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Tumor Rare Diseases Melanoma Neoplasms Uveal Melanoma
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 12.5 |
| 52 Week Low | 5.9906 |
| Average Volume | 184,225 |
| 200-Day Moving Average | 8.10 |
| 50-Day Moving Average | 7.30 |
| 20-Day Moving Average | 7.24 |
| 10-Day Moving Average | 7.18 |
| Average True Range | 0.41 |
| RSI (14) | 52.15 |
| ADX | 10.4 |
| +DI | 22.35 |
| -DI | 16.92 |
| Chandelier Exit (Long, 3 ATRs) | 6.56 |
| Chandelier Exit (Short, 3 ATRs) | 7.86 |
| Upper Bollinger Bands | 7.62 |
| Lower Bollinger Band | 6.86 |
| Percent B (%b) | 0.67 |
| BandWidth | 10.52 |
| MACD Line | -0.01 |
| MACD Signal Line | -0.05 |
| MACD Histogram | 0.0323 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 8.09 | ||||
| Resistance 3 (R3) | 8.15 | 7.97 | 7.97 | ||
| Resistance 2 (R2) | 7.97 | 7.79 | 7.94 | 7.93 | |
| Resistance 1 (R1) | 7.67 | 7.67 | 7.58 | 7.61 | 7.89 |
| Pivot Point | 7.49 | 7.49 | 7.45 | 7.46 | 7.49 |
| Support 1 (S1) | 7.19 | 7.31 | 7.10 | 7.13 | 6.85 |
| Support 2 (S2) | 7.01 | 7.19 | 6.98 | 6.81 | |
| Support 3 (S3) | 6.71 | 7.01 | 6.77 | ||
| Support 4 (S4) | 6.65 |
